Skip to content

The study of abdominal pain by elobixibat

The study of abdominal pain by elobixibat - The study of abdominal pain by elobixibat

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000033495
Enrollment
500
Registered
2018-07-24
Start date
2018-07-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional constipation

Interventions

None listed

Sponsors

Yokohama City University School of Medicine Department of Gastroenterology and Hepatology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients who are diagnosed functional constipation by ROME criteria (2) Patients who can exhibit their consent in a document

Exclusion criteria

Exclusion criteria: (1) Patients who were administered elobixibat (2) Patients who have severe psychiatric disease (3) Patients who are judged as inadequately for study entry

Design outcomes

Primary

MeasureTime frame
The relation between abdominal pain by elobixibat and the degree of improvement of constipation

Countries

Japan

Contacts

Public ContactNoboru Misawa

Yokohama City University school of medicine Department of gastroenterology and hepatology

misawa-ykh@umin.ac.jp0453707627

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026